By teasing out the biological mechanisms in pregnancy-related mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat pregnant women and new mothers at risk.
Weill Cornell Medicine has received a three-year, nearly $6 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to lead one of three national contraceptive research centers.
Twenty sophomores in the College of Arts & Sciences will design their own interdisciplinary courses of study as the newest members of the Robert S. Harrison College Scholar Program.
Over 10 weeks, 22 teams of would-be entrepreneurs developed products ranging from multilingual children's toys to innovative greenhouse hoops for small-scale farmers.
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.
Researchers in the Baker Institute for Animal Health have created a genetically engineered mouse model that could shed light on the causes of human infertility and allow researchers to explore other areas of reproduction.
A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.
The inflammatory response from adaptive immune cells – such as B and T lymphocytes – clears the body of the SARS-CoV-2 virus, but at the same time, it also causes the characteristic symptoms of COVID-19, a new study finds.
Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.